logo image
search icon
Long Read Sequencing Market

Long Read Sequencing Market Size, Share & Trends Analysis Distribution by Offerings (Consumables, Instruments, Services), Workflow (Sample Prep, Sequencing, Data Analysis), Technology (Nanopore, Single-molecule real-time sequencing, Synthetic long-read sequencing), Application, Usage, End Users and Segment Forecasts, 2023-2031

Report ID : 2694 | Published : 2024-08-19 | Pages: 168 | Format: PDF/EXCEL

The Long Read Sequencing Market Size is valued at USD 594.8 Mn in 2023 and is predicted to reach USD 4,571.3 Mn by the year 2031 at an 29.7% CAGR during the forecast period for 2024-2031.

long read sequencing

Long-read sequencing is an advanced DNA sequencing technology that allows researchers to read longer sequences of DNA, surpassing the capabilities of traditional short-read methods. This technology is essential for deciphering complex genomic structures and variations that shorter reads often miss. It is particularly valuable in genomics, providing detailed insights into structural variations, repetitive regions, and long-range genomic information, which are critical for comprehensive genome analysis.

The applications of long-read sequencing are vast and span multiple fields. It is widely used in whole genome sequencing to provide a complete view of an organism's genetic makeup, epigenetics to study DNA modifications that affect gene expression, RNA sequencing to analyze the transcriptome, and complex population studies to investigate genetic diversity. Additionally, it is utilized in targeted sequencing, focusing on specific genes or regions, particularly in clinical diagnostics. The growing prevalence of genetic disorders is a key driving factor behind the expansion of the long-read sequencing market. As the demand for accurate and comprehensive genomic data increases, long-read sequencing's ability to identify rare genetic variants and structural changes associated with diseases like cancer is propelling its adoption in both research and clinical settings.

Competitive Landscape

Some of the Key Players in Long Read Sequencing:

  • 10X Genomics, Inc.
  • Agilent Technologies, Inc.
  • Azenta US, Inc.
  • BaseClear BV
  • BGI Group
  • CD Genomics
  • Danaher Corporation
  • EdenRoc Sciences
  • Element Biosciences
  • Grandomics
  • Illumina, Inc.
  • New England Biolabs
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies plc.
  • PacBio
  • QIAGEN
  • Revvity, Inc.
  • Sage Sciences, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Cantata Bio
  • FG Technologies
  • GrandOmics
  • MicrobesNG
  • St Vincents Hospital Melbourne                               

Market Segmentation:

The long read sequencing market is segmented by offerings, technology, workflow, application, usage, end users. By offerings the market is segmented consumables, instruments, services. By technology market is categorized into nanopore sequencing, single-molecule real-time sequencing, synthetic long-read sequencing. By workflow market is categorized into sequencing, sample preparation, data analysis. By application the market is categorized into whole genome sequencing, targeted sequencing, metagenomics, epigenetics, whole exome sequencing, other applications. By usage market is categorized into research, clinical. By end users market is categorized into academic & research institutes, hospitals, clinics & diagnostic labs, pharmaceutical & biotechnology companies, other end users

Instruments Segment is Expected to Drive the Long Read Sequencing Market

The instruments segment is a key driver of the long-read sequencing market, fueled by advancements in technologies from companies like Pacific Biosciences (PacBio) and Oxford Nanopore Technologies. These sophisticated instruments enable longer DNA reads, crucial for accurately analyzing complex genomic regions and structural variations that short-read methods often miss. The growing demand for detailed genomic data in personalized medicine, cancer research, and genetic disorder diagnostics underscores the importance of these high-performance instruments. Their cost-effectiveness, real-time sequencing capabilities, and broad applicability across whole genome sequencing, epigenetics, and RNA sequencing further propel market growth by making long-read sequencing more accessible and efficient for academic and clinical use.

Nanopore Sequencing Is Growing At The Highest Rate In The Long Read Sequencing Market.

Nanopore sequencing is rapidly growing in the long-read sequencing market, driven by its real-time sequencing capabilities, versatility, and cost-effectiveness. It allows researchers to obtain immediate results, crucial for rapid decision-making in clinical diagnostics for infectious diseases and genetic disorders, while also enabling real-time monitoring and optimization of sequencing runs. Its versatility in sequencing both DNA and RNA opens applications in whole genome sequencing, targeted sequencing, metagenomics, and RNA sequencing, particularly for analyzing complex genomic regions and structural variants. Additionally, its lower operational costs and minimal sample preparation requirements make it an affordable and accessible option for a wide range of research and clinical laboratories, further fueling its adoption.

Regionally, North America Led the Long Read Sequencing Market.

North America's leadership in the long-read sequencing market is driven by its strong research infrastructure, increasing awareness and adoption, technological advancements, and significant investment in genomic research. The region is home to leading companies like Illumina, PacBio, and Oxford Nanopore Technologies, which are pioneering innovative sequencing technologies. Growing awareness of the comprehensive genomic insights provided by long-read sequencing is fueling demand among researchers and clinicians. Rapid advancements in technologies like nanopore and single-molecule real-time (SMRT) sequencing are enhancing the accessibility and effectiveness of these methods. Additionally, substantial investments from both public and private sectors in genomic research, particularly for personalized medicine and precision health, are further accelerating the adoption of long-read sequencing in North America.

Long Read Sequencing Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 594.8 Mn

Revenue Forecast In 2031

USD 4,571.3 Mn

Growth Rate CAGR

CAGR of 29.7 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Offerings, Technology, Workflow, Application, Usage, End Users and By Region

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia

Competitive Landscape

10X Genomics, Inc., Agilent Technologies, Inc., Azenta US, Inc.      , BaseClear BV, BGI Group, CD Genomics, Danaher Corporation, EdenRoc Sciences, Element Biosciences, Grandomics, Illumina, Inc., New England Biolabs, Novogene Co., Ltd., Oxford Nanopore Technologies plc., PacBio, QIAGEN, Revvity, Inc., Sage Sciences, Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., Cantata Bio, FG Technologies, GrandOmics, MicrobesNG, St Vincents Hospital Melbourne     

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape.                     

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Long Read Sequencing Market Snapshot

Chapter 4. Global Long Read Sequencing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Offerings Estimates & Trend Analysis
5.1. by Offerings & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Offerings:

5.2.1. Consumables
5.2.2. Instruments
5.2.3. Services

Chapter 6. Market Segmentation 2: by Technology Estimates & Trend Analysis
6.1. by Technology & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technology:

6.2.1. Nanopore sequencing
6.2.2. Single-molecule real-time sequencing
6.2.3. Synthetic long-read sequencing

Chapter 7. Market Segmentation 3: by Workflow Estimates & Trend Analysis
7.1. by Workflow & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Workflow:

7.2.1. Sequencing
7.2.2. Sample Preparation
7.2.3. Data analysis

Chapter 8. Market Segmentation 4: by Application Estimates & Trend Analysis
8.1. by Application & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:

8.2.1. Whole Genome Sequencing
8.2.2. Targeted Sequencing
8.2.3. Metagenomics
8.2.4. Epigenetics
8.2.5. Whole exome sequencing
8.2.6. Other applications

Chapter 9. Market Segmentation 5: by Usage Estimates & Trend Analysis
9.1. by Usage & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Usage:
9.2.1. Research
9.2.2. Clinical

Chapter 10. Market Segmentation 6: by End Users Estimates & Trend Analysis
10.1. by End Users & Market Share, 2019 & 2031
10.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End Users:

10.2.1. Academic & Research Institutes
10.2.2. Hospitals, Clinics & Diagnostic Labs
10.2.3. Pharmaceutical & Biotechnology Companies
10.2.4. Other End Users

Chapter 11. Long Read Sequencing Market Segmentation 7: Regional Estimates & Trend Analysis

11.1. North America
11.1.1. North America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Offerings, 2024-2031
11.1.2. North America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
11.1.3. North America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Workflow, 2024-2031
11.1.4. North America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.1.5. North America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2024-2031
11.1.6. North America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
11.1.7. North America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

11.2. Europe
11.2.1. Europe Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Offerings, 2024-2031
11.2.2. Europe Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
11.2.3. Europe Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Workflow, 2024-2031
11.2.4. Europe Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.2.5. Europe Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2024-2031
11.2.6. Europe Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
11.2.7. Europe Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

11.3. Asia Pacific
11.3.1. Asia Pacific Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Offerings, 2024-2031
11.3.2. Asia Pacific Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
11.3.3. Asia-Pacific Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Workflow, 2024-2031
11.3.4. Asia-Pacific Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.3.5. Asia-Pacific Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2024-2031
11.3.6. Asia-Pacific Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
11.3.7. Asia Pacific Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

11.4. Latin America
11.4.1. Latin America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Offerings, 2024-2031
11.4.2. Latin America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
11.4.3. Latin America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Workflow, 2024-2031
11.4.4. Latin America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.4.5. Latin America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2024-2031
11.4.6. Latin America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
11.4.7. Latin America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

11.5. Middle East & Africa
11.5.1. Middle East & Africa Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Offerings, 2024-2031
11.5.2. Middle East & Africa Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
11.5.3. Middle East & Africa Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Workflow, 2024-2031
11.5.4. Middle East & Africa Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.5.5. Middle East & Africa Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2024-2031
11.5.6. Middle East & Africa Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
11.5.7. Middle East & Africa Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles

12.2.1. 10X Genomics, Inc.
12.2.2. Agilent Technologies, Inc.
12.2.3. Azenta US, Inc.
12.2.4. BaseClear BV
12.2.5. BGI Group
12.2.6. CD Genomics
12.2.7. Danaher Corporation
12.2.8. EdenRoc Sciences
12.2.9. Element Biosciences
12.2.10. Grandomics
12.2.11. Illumina, Inc.
12.2.12. New England Biolabs
12.2.13. Novogene Co., Ltd.
12.2.14. Oxford Nanopore Technologies plc.
12.2.15. PacBio
12.2.16. QIAGEN
12.2.17. Revvity, Inc.
12.2.18. Sage Sciences, Inc.
12.2.19. Takara Bio Inc.
12.2.20. Thermo Fisher Scientific Inc.
12.2.21. Cantata Bio
12.2.22. FG Technologies
12.2.23. GrandOmics
12.2.24. MicrobesNG
12.2.25. St Vincents Hospital Melbourne
12.2.26. Other Prominent Players

Segmentation of Long Read Sequencing Market -

Long Read Sequencing Market by Offerings -

  • Consumables
  • Instruments
  • Services

long read sequencing

Long Read Sequencing Market by Technology -

  • Nanopore sequencing
  • Single-molecule real-time sequencing
  • Synthetic long-read sequencing

 Long Read Sequencing Market by Workflow -

  • Sequencing
  • Sample Preparation
  • Data analysis

Long Read Sequencing Market by Application -

  • Whole Genome Sequencing
  • Targeted Sequencing
  • Metagenomics
  • Epigenetics
  • Whole exome sequencing
  • Other applications

Long Read Sequencing Market by Usage -

  • Research
  • Clinical

Long Read Sequencing Market by End Users -

  • Academic & Research Institutes
  • Hospitals, Clinics & Diagnostic Labs
  • Pharmaceutical & Biotechnology Companies
  • Other End Users

Long Read Sequencing Market by Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

 

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Long Read Sequencing Market Size?

The Long Read Sequencing Market is expected to grow at an 29.7% CAGR during the forecast period for 2024-2031.

10X Genomics, Inc., Agilent Technologies, Inc., Azenta US, Inc. , BaseClear BV, BGI Group, CD Genomics, Danaher Corporation, EdenRoc Sciences, Element

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach